AF
GLSI icon

Amalgamated Financial’s Greenwich LifeSciences GLSI Stock Holding History

Amalgamated Financial’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$13K Buy
+667
New +$13.5K ﹤0.01% 2847

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Amalgamated Financial's GLSI Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Greenwich LifeSciences (GLSI) in Q1 2022: 667 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #2847 among its holdings.

34 funds tracked by Wall St. Rank hold GLSI as of Q1 2022.

  • Amalgamated Financial held 667 shares of Greenwich LifeSciences worth $13K as of Q1 2022.
  • Greenwich LifeSciences was a new Amalgamated Financial position in Q1 2022.
  • Greenwich LifeSciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2847 holding.
  • 34 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.